attachment

Interpretation

Reading Document
Medical Text Search

HPLC hemoglobin fractionation HbA2 thalassemia interpretation Bio-Rad D10

Medical Text Search

HbA2 normal range beta thalassemia trait diagnosis HPLC

GradeResponse
GradeResponse

HPLC Report Interpretation — Patient: Khushboo

Instrument: Bio-Rad D-10 | Method: HbA2/F | Date: 03/26/2026

Peak Table Summary

PeakRetention TimeArea %Interpretation
Unknown0.14 min2.3%Non-specific early eluting peak
A1b0.27 min18.5%Glycated Hb sub-fraction (includes labile HbA1c)
LA1c/CHb-10.63 min71.0%HbA0 — normal adult hemoglobin (dominant fraction)
P31.50 min1.4%Minor peak, within normal limits
A01.77 min4.0%Additional normal adult Hb fraction
A23.20 min3.1%HbA2 — KEY diagnostic value

Key Result: HbA2 = 3.1%

Normal range for HbA2: 2.0–3.5%
A value of 3.1% is within the normal range.

Interpretation

This report does NOT support a diagnosis of Beta-Thalassemia trait.
ConditionExpected HbA2
Normal2.0–3.5%
Beta-Thalassemia trait>3.5% (typically 4–8%)
Delta-Beta Thalassemia / HPFHLow/absent, elevated HbF
Alpha-Thalassemia traitNormal HbA2 (can be low-normal)
  • HbA2 of 3.1% is normal — beta-thalassemia trait is effectively excluded by this result (Harrison's, p. 2928).
  • The dominant peak is the normal adult HbA (LA1c/CHb-1 at 71%), which is expected.
  • HbF is not separately reported/elevated, making delta-beta thalassemia or HPFH unlikely.
  • The A1b fraction (18.5%) is the glycated sub-fraction and not clinically alarming in this context; note this is not equivalent to HbA1c — the D-10 in HbA2/F mode is not validated for HbA1c reporting.
  • No abnormal hemoglobin peaks (e.g., HbS at ~4.0 min, HbC at ~4.4 min, HbE) are present.

Clinical Correlation

FindingStatus
Beta-thalassemia traitNot supported (HbA2 normal)
Sickle cell trait/diseaseNot seen (no HbS peak)
HbC/HbE variantsNot seen
Abnormal hemoglobinNone detected
Conclusion: This is a normal HPLC hemoglobin fractionation pattern with no evidence of a significant hemoglobinopathy or thalassemia syndrome. If the patient has microcytosis or hypochromia on CBC, alpha-thalassemia trait should be considered (HbA2 is typically normal in alpha-thal, as seen here), and iron deficiency should be excluded. Molecular genetic testing would be needed to confirm alpha-thalassemia.
This is a shared conversation. Sign in to Orris to start your own chat.